X4 Pharmaceuticals, Inc.
XFOR
$3.18
$0.3813.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 62.95M | 86.95M | 102.06M | 134.98M | 168.75M |
| Total Receivables | 1.87M | 1.17M | 1.71M | 1.07M | 854.00K |
| Inventory | 3.17M | 3.09M | 2.82M | 2.45M | 831.00K |
| Prepaid Expenses | 4.96M | 4.48M | 5.59M | 4.48M | 4.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 72.94M | 95.70M | 112.18M | 142.97M | 175.42M |
|
|
|||||
| Total Current Assets | 72.94M | 95.70M | 112.18M | 142.97M | 175.42M |
| Net Property, Plant & Equipment | 2.90M | 4.14M | 4.84M | 5.29M | 5.68M |
| Long-term Investments | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Goodwill | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Total Other Intangibles | 9.63M | 9.81M | 10.00M | 10.19M | 10.38M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.35M | 3.01M | 2.08M | 2.36M | 1.79M |
| Total Assets | 105.17M | 130.01M | 146.45M | 178.17M | 210.61M |
|
|
|||||
| Total Accounts Payable | 7.71M | 11.12M | 8.62M | 8.58M | 7.99M |
| Total Accrued Expenses | 13.07M | 12.61M | 23.01M | 19.46M | 19.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.37M | 1.30M | 1.25M | 1.22M | 1.17M |
| Total Finance Division Other Current Liabilities | 754.00K | 855.00K | -- | -- | -- |
| Total Other Current Liabilities | 754.00K | 855.00K | -- | -- | -- |
| Total Current Liabilities | 22.90M | 25.88M | 32.88M | 29.26M | 28.90M |
|
|
|||||
| Total Current Liabilities | 22.90M | 25.88M | 32.88M | 29.26M | 28.90M |
| Long-Term Debt | 75.84M | 75.63M | 75.43M | 75.22M | 75.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 815.00K | 1.11M | 1.41M | 1.76M | 2.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.65M | 4.45M | 14.59M | 12.31M | 10.20M |
| Total Liabilities | 101.20M | 107.07M | 124.30M | 118.54M | 116.16M |
|
|
|||||
| Common Stock & APIC | 544.92M | 538.15M | 537.63M | 535.27M | 533.45M |
| Retained Earnings | -540.81M | -515.07M | -515.36M | -475.53M | -438.84M |
| Treasury Stock & Other | -138.00K | -128.00K | -122.00K | -114.00K | -159.00K |
| Total Common Equity | 3.97M | 22.94M | 22.15M | 59.62M | 94.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.97M | 22.94M | 22.15M | 59.62M | 94.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.97M | 22.94M | 22.15M | 59.62M | 94.45M |
|
|
|||||